1. Home
  2. IMRX vs PLBC Comparison

IMRX vs PLBC Comparison

Compare IMRX & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • PLBC
  • Stock Information
  • Founded
  • IMRX 2008
  • PLBC 1980
  • Country
  • IMRX United States
  • PLBC United States
  • Employees
  • IMRX N/A
  • PLBC N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • PLBC Finance Companies
  • Sector
  • IMRX Health Care
  • PLBC Finance
  • Exchange
  • IMRX Nasdaq
  • PLBC Nasdaq
  • Market Cap
  • IMRX 232.9M
  • PLBC 236.7M
  • IPO Year
  • IMRX 2021
  • PLBC 2005
  • Fundamental
  • Price
  • IMRX $6.21
  • PLBC $42.40
  • Analyst Decision
  • IMRX Strong Buy
  • PLBC Buy
  • Analyst Count
  • IMRX 4
  • PLBC 4
  • Target Price
  • IMRX $17.75
  • PLBC $57.00
  • AVG Volume (30 Days)
  • IMRX 3.5M
  • PLBC 20.0K
  • Earning Date
  • IMRX 11-12-2025
  • PLBC 10-17-2025
  • Dividend Yield
  • IMRX N/A
  • PLBC 2.84%
  • EPS Growth
  • IMRX N/A
  • PLBC 1.22
  • EPS
  • IMRX N/A
  • PLBC 4.86
  • Revenue
  • IMRX N/A
  • PLBC $84,003,000.00
  • Revenue This Year
  • IMRX N/A
  • PLBC $22.16
  • Revenue Next Year
  • IMRX N/A
  • PLBC $17.58
  • P/E Ratio
  • IMRX N/A
  • PLBC $8.70
  • Revenue Growth
  • IMRX N/A
  • PLBC 6.85
  • 52 Week Low
  • IMRX $1.10
  • PLBC $37.69
  • 52 Week High
  • IMRX $10.08
  • PLBC $51.33
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 47.03
  • PLBC 44.10
  • Support Level
  • IMRX $6.02
  • PLBC $41.50
  • Resistance Level
  • IMRX $9.54
  • PLBC $43.16
  • Average True Range (ATR)
  • IMRX 0.96
  • PLBC 0.90
  • MACD
  • IMRX -0.36
  • PLBC -0.20
  • Stochastic Oscillator
  • IMRX 4.68
  • PLBC 22.73

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About PLBC Plumas Bancorp

Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.

Share on Social Networks: